Quetiapine Fumarate
Product Images NDC 50090-5451
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50090-5451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse (study 3) (Quetiapine Fig1)
The text describes a figure containing Kaplan-Meier curves showing the time to relapse for schizophrenic patients in study 3. The X-axis represents time in months, and the Y-axis represents the proportion of patients with relapse (%). The figure includes curves for PLA (placebo), QTP (quetiapine), and ER (extended-release). The results depicted are from an interim analysis.*
Figure 3 (Quetiapine Fig2)
Figure 3 (Quetiapine Fig3)
This appears to be a graph showing the proportion of patients with relapse over time (in weeks) using Kaplan-Meier curves. The data pertains to a study focused on time to recurrence of a mood event. The graph shows the percentage of patients experiencing relapse over the course of the study. There are some illegible characters and a seemingly random sequence of letters and numbers at the bottom of the graph, which is not relevant to the main content.*
Chemical Structure (Quetiapine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.